학술논문
A prospective, multi-centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma
Document Type
Article
Author
Source
In: Veterinary and Comparative Oncology . (Veterinary and Comparative Oncology, March 2022, 20(1):293-303)
Subject
Language
English
ISSN
14765829
14765810
14765810